Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,797,488 papers from all fields of science
Search
Sign In
Create Free Account
TRAPPC9 gene
Known as:
IKBKBBP
, NIK- AND IKBKB-BINDING PROTEIN
, tularik gene 1
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation
N. Dudhipala
,
Kishan Veerabrahma
Drug Delivery
2016
Corpus ID: 39549827
Abstract Candesartan cilexetil (CC) is used in the treatment of hypertension and heart failure. It has poor aqueous solubility…
Expand
Highly Cited
2015
Highly Cited
2015
Validation of the Somnotouch-NIBP noninvasive continuous blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010
G. Bilo
,
C. Zorzi
,
Juan E. Ochoa Munera
,
C. Torlasco
,
V. Giuli
,
G. Parati
Blood Pressure Monitoring
2015
Corpus ID: 15593926
ObjectiveThe present study aimed to evaluate the accuracy of the Somnotouch-NIBP noninvasive continuous blood pressure monitor…
Expand
Highly Cited
2009
Highly Cited
2009
A truncating mutation of TRAPPC9 is associated with autosomal-recessive intellectual disability and postnatal microcephaly.
G. Mochida
,
M. Mahajnah
,
+10 authors
C. Walsh
American Journal of Human Genetics
2009
Corpus ID: 29132056
Highly Cited
2009
Highly Cited
2009
Identification of mutations in TRAPPC9, which encodes the NIK- and IKK-beta-binding protein, in nonsyndromic autosomal-recessive mental retardation.
Asif Mir
,
L. Kaufman
,
+17 authors
J. Vincent
American Journal of Human Genetics
2009
Corpus ID: 25869741
Review
2006
Review
2006
IκB kinase complexes: gateways to NF-κB activation and transcription
C. Scheidereit
Oncogene
2006
Corpus ID: 7017330
Transcription factors of the NF-κB family regulate hundreds of genes in the context of multiple important physiological and…
Expand
Highly Cited
2003
Highly Cited
2003
Multi-purpose HealthCare Telemedicine Systems with mobile communication link support
E. Kyriacou
,
E. Kyriacou
,
+10 authors
D. Koutsouris
BioMedical Engineering OnLine
2003
Corpus ID: 5670283
The provision of effective emergency telemedicine and home monitoring solutions are the major fields of interest discussed in…
Expand
Review
1998
Review
1998
Fifteen years experience with finger arterial pressure monitoring: assessment of the technology.
B. Imholz
,
W. Wieling
,
G. A. Montfrans
,
K. Wesseling
Cardiovascular Research
1998
Corpus ID: 1344921
Highly Cited
1996
Highly Cited
1996
The impact of a national impregnated bed net programme on the outcome of pregnancy in primigravidae in The Gambia.
U. d’Alessandro
,
P. Langerock
,
S. Bennett
,
N. Francis
,
K. Cham
,
B. Greenwood
Transactions of the Royal Society of Tropical…
1996
Corpus ID: 22041684
Highly Cited
1994
Highly Cited
1994
SERUM CYTOKINES (IL-6, TNF-α, IL-1β AND IFN-γ) IN ANKYLOSING SPONDYLITIS: A CLOSE CORRELATION BETWEEN SERUM IL-6 AND DISEASE ACTIVITY AND SEVERITY
J. Gratacós
,
A. Collado
,
+6 authors
J. Muñoz‐Gómez
1994
Corpus ID: 73028690
: The aim of our study was to analyse the serum interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-alpha), interleukin-1…
Expand
Highly Cited
1994
Highly Cited
1994
Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity.
J. Gratacós
,
A. Collado
,
+6 authors
J. Muñoz‐Gómez
British Journal of Rheumatology
1994
Corpus ID: 40969177
The aim of our study was to analyse the serum interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-alpha), interleukin-1 beta…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE